4//SEC Filing
Belloff Neil S. 4
Accession 0001415889-21-002227
CIK 0001035354other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 10:15 AM ET
Size
9.3 KB
Accession
0001415889-21-002227
Insider Transaction Report
Form 4
Belloff Neil S.
General Counsel and Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-04-30+1,562→ 27,639 total - Exercise/Conversion
Restricted Stock Units
2021-04-30−1,562→ 10,938 total→ Common Stock (1,562 underlying) - Tax Payment
Common Stock
2021-04-30$2.18/sh−459$1,001→ 27,180 total
Footnotes (4)
- [F1]The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F4]The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated with certain qualifying terminations of service or in connection with a corporate transaction.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001741670
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 10:15 AM ET
- Size
- 9.3 KB